IMMUNITYBIO, INC. Share-based Payment Arrangement, Decrease for Tax Withholding Obligation
IMMUNITYBIO, INC. (IBRX) reported Share-based Payment Arrangement, Decrease for Tax Withholding Obligation of $319.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Notes
us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation · last filed 2026-08-04
- IMMUNITYBIO, INC. share-based payment arrangement, decrease for tax withholding obligation for the quarter ending 2026-06-30 was $319.00K, a 0.93% decline year-over-year.
- IMMUNITYBIO, INC. share-based payment arrangement, decrease for tax withholding obligation for the quarter ending 2026-03-31 was $6.99M, a 481.86% increase year-over-year.
- IMMUNITYBIO, INC. share-based payment arrangement, decrease for tax withholding obligation for the quarter ending 2025-09-30 was $151.00K, a 49.50% decline year-over-year.
- IMMUNITYBIO, INC. share-based payment arrangement, decrease for tax withholding obligation for the quarter ending 2025-06-30 was $322.00K, a 35.08% decline year-over-year.
- IMMUNITYBIO, INC. share-based payment arrangement, decrease for tax withholding obligation for fiscal 2025 was $2.27M, a 58.55% decline from fiscal 2024.
- IMMUNITYBIO, INC. share-based payment arrangement, decrease for tax withholding obligation for fiscal 2024 was $5.46M, a 58.73% increase from fiscal 2023.
- IMMUNITYBIO, INC. share-based payment arrangement, decrease for tax withholding obligation for fiscal 2023 was $3.44M, a 458.93% increase from fiscal 2022.
- IMMUNITYBIO, INC. share-based payment arrangement, decrease for tax withholding obligation for fiscal 2022 was $616.00K, a 84.84% decline from fiscal 2021.
| Period end | Share-based Payment Arrangement, Decrease for Tax Withholding Obligation 3 month | Share-based Payment Arrangement, Decrease for Tax Withholding Obligation 6 month | Share-based Payment Arrangement, Decrease for Tax Withholding Obligation 9 month | Share-based Payment Arrangement, Decrease for Tax Withholding Obligation 12 month |
|---|---|---|---|---|
| 2026-06-30 | $319.00K 10-Q · filed 2026-08-04 | $7.31M derived: sum of 2 quarters · filed 2026-08-04 | ||
| 2026-03-31 | $6.99M 10-Q · filed 2026-08-04 | |||
| 2025-12-31 | $2.27M 10-K · filed 2026-02-23 | |||
| 2025-09-30 | $151.00K 10-Q · filed 2025-11-05 | $473.00K derived: sum of 2 quarters · filed 2026-08-04 | $1.68M derived: sum of 3 quarters · filed 2026-08-04 | |
| 2025-06-30 | $322.00K 10-Q · filed 2026-08-04 | $1.52M derived: sum of 2 quarters · filed 2026-08-04 | ||
| 2025-03-31 | $1.20M 10-Q · filed 2026-08-04 | |||
| 2024-12-31 | $5.46M 10-K · filed 2026-02-23 | |||
| 2024-09-30 | $299.00K 10-Q · filed 2025-11-05 | $795.00K derived: sum of 2 quarters · filed 2025-11-05 | $4.66M derived: sum of 3 quarters · filed 2025-11-05 | |
| 2024-06-30 | $496.00K 10-Q · filed 2025-11-05 | $4.36M derived: sum of 2 quarters · filed 2025-11-05 | ||
| 2024-03-31 | $3.87M 10-Q · filed 2025-11-05 | |||
| 2023-12-31 | $3.44M 10-K · filed 2026-02-23 | |||
| 2023-09-30 | $1.46M 10-Q · filed 2024-11-12 | $1.52M derived: sum of 2 quarters · filed 2024-11-12 | $1.88M derived: sum of 3 quarters · filed 2024-11-12 | |
| 2023-06-30 | $60.00K 10-Q · filed 2024-11-12 | $417.00K derived: sum of 2 quarters · filed 2024-11-12 | ||
| 2023-03-31 | $357.00K 10-Q · filed 2024-11-12 | |||
| 2022-12-31 | $616.00K 10-K · filed 2025-03-03 | |||
| 2022-09-30 | $10.00K 10-Q · filed 2023-11-09 | $25.00K derived: sum of 2 quarters · filed 2023-11-09 | $397.00K derived: sum of 3 quarters · filed 2023-11-09 | $877.00K derived: sum of 4 quarters · filed 2024-03-19 |
| 2022-06-30 | $15.00K 10-Q · filed 2023-11-09 | $387.00K 10-Q · filed 2022-08-08 | $867.00K derived: sum of 3 quarters · filed 2024-03-19 | $1.83M derived: sum of 4 quarters · filed 2024-03-19 |
| 2022-03-31 | $372.00K 10-Q · filed 2023-11-09 | $852.00K derived: sum of 2 quarters · filed 2024-03-19 | $1.81M derived: sum of 3 quarters · filed 2024-03-19 | $1.81M derived: sum of 4 quarters · filed 2024-03-19 |
| 2021-12-31 | $480.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-19 | $1.44M derived: sum of 2 quarters · filed 2024-03-19 | $1.44M derived: sum of 3 quarters · filed 2024-03-19 | $4.06M 10-K · filed 2024-03-19 |
| 2021-09-30 | $960.00K 10-Q · filed 2022-11-09 | $960.00K derived: sum of 2 quarters · filed 2022-11-09 | $3.58M 10-Q · filed 2021-11-12 | $3.60M derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-06-30 | $0.00 10-Q · filed 2022-11-09 | $2.62M 10-Q · filed 2022-08-08 | $2.64M derived: sum of 3 quarters · filed 2023-03-01 | $2.96M derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-03-31 | $2.62M 10-Q · filed 2022-11-09 | $2.64M derived: sum of 2 quarters · filed 2023-03-01 | $2.96M derived: sum of 3 quarters · filed 2023-03-01 | $3.00M derived: sum of 4 quarters · filed 2023-03-01 |
| 2020-12-31 | $18.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $339.00K derived: sum of 2 quarters · filed 2023-03-01 | $379.00K derived: sum of 3 quarters · filed 2023-03-01 | $503.00K 10-K · filed 2023-03-01 |
| 2020-09-30 | $321.00K 10-Q · filed 2021-11-12 | $361.00K derived: sum of 2 quarters · filed 2021-11-12 | $485.00K 10-Q · filed 2021-11-12 | $545.00K derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-06-30 | $40.00K 10-Q · filed 2021-08-12 | $163.00K 10-Q · filed 2021-08-12 | $224.00K derived: sum of 3 quarters · filed 2022-03-01 | $264.00K derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-03-31 | $123.00K 10-Q · filed 2021-05-14 | $184.00K derived: sum of 2 quarters · filed 2022-03-01 | $224.00K derived: sum of 3 quarters · filed 2022-03-01 | $224.00K derived: sum of 4 quarters · filed 2022-03-01 |
| 2019-12-31 | $61.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $101.00K derived: sum of 2 quarters · filed 2022-03-01 | $101.00K derived: sum of 3 quarters · filed 2022-03-01 | $127.00K 10-K · filed 2022-03-01 |
| 2019-09-30 | $40.00K 10-Q · filed 2019-11-05 | $40.00K derived: sum of 2 quarters · filed 2019-11-05 | $66.00K 10-Q · filed 2019-11-05 | |
| 2019-06-30 | $0.00 10-Q · filed 2019-08-06 | $26.00K 10-Q · filed 2019-08-06 | ||
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-04 | $0.00 derived: sum of 2 quarters · filed 2021-03-04 | $50.00K derived: sum of 3 quarters · filed 2021-03-04 | $123.00K 10-K · filed 2021-03-04 |
| 2018-09-30 | $0.00 10-Q · filed 2019-11-05 | $50.00K derived: sum of 2 quarters · filed 2019-11-05 | $123.00K 10-Q · filed 2019-11-05 | |
| 2018-06-30 | $50.00K 10-Q · filed 2019-08-06 | $123.00K 10-Q · filed 2019-08-06 | ||
| 2017-12-31 | $1.04M 10-K · filed 2020-03-25 | |||
| 2016-12-31 | $1.11M 10-K · filed 2019-03-13 | |||
| 2015-12-31 | $2.42M 10-K · filed 2018-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| CG Oncology, Inc. (CGON) | United States | $6.095B | -27.95 |
| Scholar Rock Holding Corp (SRRK) | United States | $5.920B | -16.37 |
| CRISPR Therapeutics AG (CRSP) | $5.390B | -11.68 |